Lilly S.A., Alcobendas, Spain – FDA Inspections

Inspection records and compliance data for Lilly S.A. in Alcobendas. 4 FDA inspections on record, last inspected February 14, 2024.

Company Profile

This profile covers Lilly S.A. based in Alcobendas, Spain.

FDA Inspection History

FDA inspections: 4
OAI: 0
VAI: 2
NAI: 2
Form 483s: 0
Warning letters: 0

First inspected October 18, 2013. Last inspected February 14, 2024.

FDA inspections (4)

Date	Result	FDA center(s)	Insp. #
February 14, 2024	NAI	Human Drugs · Drug Quality Assurance	1299118
March 9, 2021	VAI	Human Drugs · Drug Quality Assurance	1204907
March 15, 2018	VAI	Human Drugs · Drug Quality Assurance	1118460
October 18, 2013	NAI	Human Drugs · Drug Quality Assurance	853424

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Other regulators (1)

Health Canada · 1 inspection · last June 21, 2012

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Blistex Inc

Alkermes Inc

Annora Pharma Private Limited

Shire Human Genetic Therapies, Inc.

Catalent Pharma Solutions, LLC

Towa Pharmaceutical Europe, S.L.

MSN Laboratories Private Limited (Formulations Division, Unit-II)

ZYDUS LIFESCIENCES LIMITED

Graviti Pharmaceuticals Private Limited

J. B. Chemicals and Pharmaceuticals Limited